Market Research Blog – Page 9174 – New Product Development

Narcolepsy Treatment Market is expected to reach US$ 6.67 Bn by the end of 2028, with sales revenue expected to register 5.7% CAGR growth.

Revenue from narcolepsy treatment globally is projected to stand at a valuation of US$ 6.67 Bn, registering an annual growth rate of 5.7 %, from 2022-2028. Future Market Insights (FMI), in its newly published market intelligence outlook, highlights substantial demand for narcolepsy treatment in North America.

The global Narcolepsy Treatment Market is estimated at USD 4.77 billion in 2022 and is projected to reach USD 6.67 billion by 2028

Data Points	Market Insights
Market Value 2021	US$ 4.50 Bn
Market Value 2022	US$ 4.77 Bn
Market Value 2028	US$ 6.67 Bn
CAGR 2022-2028	5.7%
Market Share of Top 5 Countries	54.4%
Key Industry Players	ResMed Inc., Koninklijke Philips N.V., Merck & Co. Inc., Drive DeVilbiss Healthcare LLC, GlaxoSmithKline Plc., Fisher & Paykel Healthcare Limited, Pfizer Inc.

Narcolepsy treatment landscape in Europe, will witness significant revenue growth given the rising affinity toward adoption of prescription treatments and adherence to the same on a long term basis.

Request for Report Sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-7641

Asia Pacific among other emerging economies including MEA and Latin America, on the other hand, are expected to showcase positive trends towards the adoption of narcolepsy treatment, due to:

Strong distribution pipeline of the narcolepsy drugs.
Emerging global and local biopharmaceutical companies.
Increasing incidences of Obstructive Sleep Apnea (OSA) in Latin America. Obesity is reported to be the most common risk factor.
Prevalence of moderately severe sleep apnea is estimated to be around 5% in women and 10% in men in South Africa. It is estimated that up to 90% of patients are undiagnosed.
Prevalence of sleep apnea is more severe in the developing countries due to the lack of skilled physicians

In term of key forward market strategies, the primary objective manufacturers in the narcolepsy treatment market is to expand their footprint in the various regional markets, in order to solidify their market position.

Key Findings from the Regional and Competitive Landscape Analysis of Narcolepsy Treatment Market

Leading narcolepsy treatment manufacturers are prioritizing regional-specific product development. The product portfolio expansion is mostly targeted in Asia Pacific.
Apart from new product development—mostly arising from the presence of low cost generic versions of patented drugs, strategic partnerships and acquisitions with pave way for further business expansions.
Manufacturers in the global narcolepsy treatment are also focused towards introducing new research and development units in different geographic regions.
Industry leaders are focusing on maintaining long-term partnerships with pharmacies- in hospital and retail, drug stores, and e-commerce. Sales through e-commerce distribution channel is expected to contribute a significant revenue share in the global narcolepsy treatment market.
FMI, has also noted an increasing focus on reformulation of well-known products and combinations, by manufacturers in North America in order to achieve higher sales and wide penetration.

There is a conscious shift from OTC medication to devices treating narcolepsy, driving significant revenue growth for the devices segment compared to drugs. Growing incidences of inappropriate medication and addiction, translating into severe side effects including headache, prolonged drowsiness, daytime memory and performance problems, allergic reactions, and death in some cases, is the key driving factor. These side effects are associated with OTC as well as prescription-based sleep aids.

Speak to our Research Expert: https://www.futuremarketinsights.com/ask-question/rep-gb-7641

Growing demand to treat narcolepsy with BiPAP is expected to push this segment of devices—predicted to expand at the highest CAGR. Moreover, devices in portable and available-for-rent formats, will translate into higher adoption rates, throughout the forecast period. Portable Continuous positive airway pressure (CPAP) devices are lighter and smaller and can also be used as a home based unit, further reducing the dependency on OTC pills and prescription drugs.

While explaining the growth trajectory of narcolepsy treatment market, a senior analyst from the healthcare domain underscores growing healthcare expenditure and rising incidence cases of fracture fixation and orthopedic disorders as key factors contributing to the demand of narcolepsy treatment though 2028. “Regulatory impositions by various global authorities including the FDA and European Commission along with currency fluctuations, regulations and changing taxation policies are some high-impact factors pushing the global demand for narcolepsy treatment”, the analyst further explains.

Report Scope as Per Narcolepsy Treatment Industry Analysis

Attribute	Details
Forecast Period	2022-2028
Historical Data Available for	2013-2021
Market Analysis	US$ Mn for Value
Key Regions Covered	North America, Latin America, Europe, APAC, Middle East & Africa (MEA)
Key Countries Covered	US, Canada, Brazil, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, China, Japan, India, ASEAN, Australia, New Zealand, South Africa and GCC Countries
Key Market Segments Covered	Product, Distribution Channel and Region
Key Companies Profiled	• ResMed Inc. • Koninklijke Philips N.V. • Merck & Co. Inc. • Drive DeVilbiss Healthcare LLC • GlaxoSmithKline Plc. • Fisher & Paykel Healthcare Limited • Pfizer Inc.

Ask for Country-Specific Data@ https://www.futuremarketinsights.com/ask-country-specific/rep-gb-7641

Critical Market Restrainers

Although the narcolepsy market is expanding at a robust CAGR, long waiting time for sleep services, lack of awareness and delayed diagnosis, severe side effects of sleep aids medication, lack of proper documentation for the usage and licensing of sleeping pills, and improper equipment regulations are some critical factors projected to restrain the growth of narcolepsy treatment market.

Explore Other Reports Links From Healthcare Market:

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Aluminum Oxide Coated Films Market Future Trends, Industry Size and Forecast to 2028

The role of packaging in healthcare, food, beverage, premium cosmetics and few industries is significant for the protection of products from environmental conditions. Various barrier materials such as ethylene vinyl alcohol (EVOH), polyvinylidene dene chloride (PVdC) and others are incorporated widely for a barrier against moisture, oxygen, and odor.

These high barrier materials cost much higher than the aluminum oxide coated films due to limited availability. Aluminum oxide coated films combines the low cost and high machinability for the production of packaging products, with the barrier properties of aluminum oxide. These factors have driven the aluminum oxide coated films.

The below data shows that aluminum material was accounted for around 20% of the high barrier packaging films for pharmaceutical industry. This includes aluminum foil, aluminum sheet and the aluminum oxide coated films.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6562

Global Aluminum Oxide Coated Films Market Developments

The aluminum oxide coated films provides sufficient barrier characteristics to the packaging. Moreover, for the application in premium products which cannot afford even low intensity of contamination, barrier films such as ethylene vinyl alcohol (EVOH) and polyamide (PA) are used as a substrate for barrier coating and results into highly efficient barrier material for packaging applications.

Multilayer polyolefin films are used as a substrate for aluminum oxide coated films which results in additional features such as heat sealing, adhesive, high printability and others. The major driving factor of aluminum oxide coated films market is the transparency.

Due to the high preference for transparent packaging in food and some other consumer products added to the high barrier property, aluminum oxide coated films are one of the leading material for producing primary packaging products.

Due to the high availability of aluminum in Asia Pacific region, the cost of aluminum oxide coating is a comparatively low region, the production of oxide coated films is expected to be the largest in the region. The demand for packaged foods and healthcare products is very high in the North America market, indicating a large opportunity for aluminum oxide coated films market in the region.

Global Aluminum Oxide Coated Films Market Key Players

Some of the key players in the global aluminum oxide coated films market are

3M Company
Uflex Ltd.
Celplast Metallized Products Limited
Toray Plastics Inc.
Rollprint Packaging Products, Inc.
Innovia Films Limited
DUNMORE Corporation
michelman, inc.
Films Americas LLC

A large number of producers of oxide coating materials are uniformly distributed across the globe serving the demand of packaging film manufacturers. Therefore, the capability of aluminum oxide coated film manufacturers are dependent on the production technology incorporated by the manufacturer. The 3M Company, Innovia Films, Dunmore Corporation and few others are the key players with high production capacity and serving the global market.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-6562

Some of the emerging players of the global aluminum oxide coated films market are

Ultimet Films Ltd.
JBF RAK LLC
Kemet International Limited
Allied High Tech Products, Inc.
Kai Bao Precision Machinery Co., Ltd.
UACJ Corporation
Nanolap Technologies, LLC
Eurocast Sp. z o.o.
Kankriya Enterprises Pvt Ltd
Vacmet India Ltd
Knowfort Technologies BV

Due to high availability and low cost of the machinery and raw materials required for the production of aluminum oxide coated films market, a large number of regional players are emerging in the Asia Pacific region. While the preference of the leading global companies of packaging solution providers towards high quality and expensive brands has driven the market share of global top leading companies in Western Europe and North America region.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-6562

Global Aluminum Oxide Coated Films Market Segmentation

The global aluminum oxide coated films market can be segmented by the material of substrate as

Polyester (PS)
Polypropylene (PP)
Polyamide (PA)
Polylactic acid (PLA)
Polyethylene Terephthalate (PET)

The global aluminum oxide coated films market can be segmented by film thickness as

Up to 1 micron
1 to 5 micron
5 to 12 micron
Above 12 micron

On the basis of end use, FTIR gas analysers market segmented into:

Food
Beverage
Pharmaceuticals
Cosmetics & personal care
Consumer electronics
Others

The global aluminum oxide coated films market can be segmented by the geographical regions as

North America
Latin America
Western Europe
Eastern Europe
Middle East & Africa
Asia Pacific excluding Japan (APEJ)
Japan

About Us:

Contact Us:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs

End Caps Market Expected to Witness High Growth by 2028

The root of packaging in today’s world profoundly resides in the safety of goods & appliances from exterior damage throughout its loading and shipment. Hence, in the market, numerous protective packaging solutions are easily available which offers enhanced safety values to the package from diverse industries, with end caps as one of the novel solution that adheres to the elementary property of protection.

End caps are durable, lightweight and custom-made inserts usually made from foam, molded pulp, etc. which usually form a shock absorbent protective surface that provides cushioning. End caps transforms a standard case / box into a secure and well-insulated delivery container thus reducing the damage quotient during the course of product transition is carried out.

End caps are designed to fit in custom-designed containers such as corrugated boxes / cases, etc. and act as cushions that sentinel delicate product against any impairment due to unexpected impact for the duration of carriage between manufacturers, retailers, distributors, and end use. End use are applied in safe transport of electronic appliances, automotive spare parts, consumer products, etc.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4856

End caps find a wide range of applications in packaging of consumer electronics, automotive spares parts, furniture and other industrial products, especially for cushioning the outer-edges of the fragile and expensive products.

Global end caps market: Key Players

Some key players that currently operate in partition inserter machines market across the globe can be segmented into three tiers based on their market share as follows

Tier 1 (includes market leaders with a market share of more than 3%)
- Smurfit Kappa Group plc.
- Packaging Corporation of America
- Storopack Hans Reichenecker GmbH
Tier 2 (includes market players with a market share above 1% and below 3%)
- Cascades Inc
- 5 STAR PACKAGING, INC.
- UFP Technologies, Inc.
- Plastifoam Company
- ACH Foam Technologies
- Pregis Corporation.
- Ranpak Corp
Tier 3 (includes manufacturers with market share below 1%)
- Technifoam, Inc.
- Synergy Packaging Pvt. Ltd

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-4856

Key Product Launches

In March 2018, Macfarlane Packaging, the UK’s largest distributor of protective packaging materials introduced a new range of innovative packing products – during a weak long “Packaging Innovations Event” at the Birmingham NEC.

In September 2017, DuPont Protection Solutions newly introduced DuPont™ Tyvek® 40L medical packaging, a new class of Tyvek® for medical packaging applications, specially designed to provides a cost-effective choice for protecting lightweight devices..

Future Prospects

Increasing awareness among the product manufacturers to curb transit damage thus to a large extent eliminating costly replacements and scraps and are expected to upsurge the demand for protective packaging such as end caps market. Mounting global population getting involved in online trading is expected to contribute substantially to the E-commerce packaging market’s growth and in terms adding positivity to the end caps market.

For high market acceptance, the design has to be durable, impact resistant and light-in-weight, which incurs least shipping / transportation cost and all the above clauses are pleased by protective packaging end caps. Thus, the outlook for the growth of the global end caps market is projected to stay positive, during the forecast period.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-4856

Global End Caps market: Segmentation

The global end caps market has been segmented as follows –

On the basis of material type, the global end caps market has been segmented as –

Paper & Paperboard
Corrugated board
Molded Fiber
Foam Board
Expanded polystyrene (EPS)
Extruded polystyrene (XPS)
Polyisocyanurate (Polyiso, ISO)
Plastic
Polyethylene (PE)
Polyvinyl Chloride (PVC)
Polystyrene (PS)
Others
Rubber

On the basis of end caps designs, the global end caps market has been segmented as –

Traditional end cap set
Ribbed end cap set
Hingelock end cap set
Others

On the basis of end use industry, the global end caps market has been segmented as –

Electronics goods & appliances packaging
Consumer goods packaging
Automotive spares parts packaging
Furniture packaging
Industrial packaging
Food & beverage
Home & Personal Care
Pharmaceuticals
Other industries

About Us:

Contact Us:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs

Period Patch Market Set to Witness an Uptick Size US$ 1.9 Bn to 2032: Future Market Insights, Inc.

The global period patch market size is poised to grow from US$ 1.2 Bn in 2022 to US$ 1.9 Bn by 2032, exhibiting a CAGR of 4% between 2022 and 2032.

Increasing prevalence of menstrual cramps, introduction of herbal products, and growing health awareness among people are some of the key factors driving demand for period patches.

The feminine care sector is being transformed by the women-owned period brands, which offer tailored birth control products, efficient pain alleviation, and leak-proof solutions. The main focus of the players is on giving women more portable products.

Dysmenorrhea, or menstrual cramps, are sharp or stabbing pains in the lower abdomen of women before and during periods. Some ladies may only find the discomfort irritating. Others may experience menstrual cramps that are so bad that they prevent them from going about their normal lives for a few days each month.

In order to treat the severe period cramps, industry manufacturers are developing items like period patches. For instance, the award-winning product innovation company Sirona is dedicated to resolving the intimate and menstrual hygiene problems that women face worldwide but which are not fully addressed.

The “Beginner’s Pain Relief Patch” from Sirona is a wholly ayurvedic patch. In the beginning of the monthly cycle, it is one of the safest methods for preventing cramps. It is anticipated that rise in product offering will eventually increase period patch sales across the globe

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15475

Similarly, introduction of period patches with ayurvedic formulas are penetrating the market at a robust pace. This will further expand the global period patch market size during the forecast period.

Key Takeaways from the Period Patch Market Study

By product type, the heated period patch segment is expected to grow at a CAGR of 4.0% during the forecast period.
In terms of price range, US$ 20- US$ 30 segment has the most market share and is expected to grow at the fastest pace over the assessment period.
Due to changing consumer preferences for new and improved products, North America accounted for the largest share of the period patch market.
The U.S. period patch market is expected to surge at around 4.0% CAGR through 2032.
Demand for period patches across India is likely to grow at a CAGR of ~5.0% during the forecast period of 2022 and 2032

“Leading manufacturers in the global period patch market have raised their R&D efforts with the goal of expanding their product line. Besides this, in an effort to grow their clientele and establish a stronger global presence, businesses are focusing on the new prospective market, ” says the FMI analyst.

Who is winning?

Leading manufacturers of period patch are focused on aggressive promotional strategies, advertisements, and new product launches that have driven sales growth of period patch globally.

Major players present in the period patch market Unexo Life Sciences Pvt. Ltd., Cora, La Mend Inc. dba, The Good Patch, LILAS WELLNESS, Rael, Nua Lagom Labs Private Limited, Care me Inc., Popband Ltd., BeYou, BeBodywise, sirona hygiene private limited, Medi Heally Philippines, Sparsha Pharma International Pvt Ltd among others.

For More Information or Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-15475

Get More Valuable Insights

Future Market Insights, in its new offering, provides an unbiased analysis of the global period patch market, presenting historical demand data (2017-2021) and forecast statistics for the period from 2022-2032. The study divulges compelling insights on the period patch market based on the period patch market by product type (cool & heated period patch), price range (below US$ 20, US$ 20- US$ 30, US$ 30-US$ 40 and Above US$ 40) sales channel (direct sales, specialty stores, drug stores, departmental stores, online retailers & other sales channel) across seven major regions.

Competitive Landscape

Leading players operating in the market are focusing on expansion, partnership, development, and new product launches in order to expand their business globally.

For instance:

Nearly 70% of menstrual women in India have cramps, which can disrupt sleep and lead to abnormal mood swings, irritability, and exhaustion. Women’s health company Nua has introduced a cutting-edge self-heating patch in 2020 that is specially created to produce up to 8 hours of heat to provide period pain relief.

Cora, La Mend Inc. dba The Good Patch, and BeYou Emerging Top Three Flag Bearers in Period Patch Space!

Cora, La Mend Inc. dba The Good Patch, and BeYou are the top three players manufactures of period patches. Headquartered in San Francisco, California, Cora has become a leading provider of period care and organic period care. The company was founded in 2015 and since then its specialities has expanded significantly.

Recently, Cora introduced their new comfort-focused brand look and expanded its portfolio with new wellness products to meet consumer demands. The new products include “The Comfort Fit Tampon, The Peace-of-Mind Pad, The Got-You-Covered Liner, and The Perfect Fit Disc.

Similarly, La Mend Inc. dba The Good Patch has emerged as a leading provider of period care products. The company offers a variety of wellness items and patches for everyday ailments. The business uses tried-and-true ingredients that are vegan and third-party-tested components that are of the highest purity and standard. People can buy them online through company’s website and in a number of big-box stores like Target, Ulta, and CVS, as well as in spas and boutiques all over the country.

Contact Sales for Further Assistance in Purchasing this Report @
https://www.futuremarketinsights.com/checkout/15475

Global Period Patch Market by Category

By Product Type:

Cool Period Patch
Heated Period Patch

By Price Range:

Below US$ 20
US$ 20- US$ 30
US$ 30- US$ 40
Above US$ 40

By Sales Channel:

Direct Sales
Specialty Stores
Pharmacy / Drug Stores
Departmental Stores
Online Retailers
Other Sales Channel

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
MEA

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Summary of Key Findings

1.3. Summary of Key statistics

1.4. FMI Analysis and Recommendations

2. Market Overview

2.1. Market Taxonomy

2.2. Market Definition

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation Trends

To Continue TOC…

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com

Homecare Dermatology Energy-based Devices Market Top Trends and industry overview to watch for in 2028

Growing commercialization of advanced technology in homecare dermatology and frequent introduction of user-friendly dermatology services are collectively boosting the growth prospects for homecare dermatology energy-based devices landscape at a global level.

According to a newly released intelligence report by Future Market Insights, exhibiting nearly 5% year over year growth in revenue, the global homecare dermatology energy-based devices landscape is likely to be worth over US$ 550 Mn in 2020. While maximum incremental opportunity is projected for China and APEC, North America – despite being the global leader – is likely to witness moderate growth in coming years.

Rapidly growing demand for homecare devices as a result of a paradigm shift from conventional clinics to in-house, non-invasive energy treatments is prominently responsible for healthy revenue growth projections for homecare dermatology energy-based devices.

Technological advancements in these devices are widening their application base, thereby pushing the rate of adoption further at a global level. Another strong push factor associated with homecare dermatology energy-based devices includes their availability as the OTC products.

Product type analysis of market landscape reveals that laser and IPL (intense pulsed light) equipment are enjoying the highest sales, whereas LED equipment is projected to emerge as the most attractive segment in homecare dermatology energy based devices space in the near future.
Hair removal and acne, followed by wrinkles treatment, are reportedly the most extensively sought after applications of homecare dermatology energy based devices.
E-commerce dominates all other distribution channels, according to the report. Hyper markets and super markets also remain among the preferred channels for product distribution.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-7699

A Bird’s Eye View of the Global Landscape

“The global market for homecare dermatology energy based devices is a highly consolidated landscape, wherein the top two players collectively account for around 60% share of the market revenue. Koninklijke Philips, with more than a third of the market value share, secures the top position with its extensive portfolio of intense pulsed light devices used for hair removal,” explains a senior research analyst while offering the inclusions of the company’s recent report on the global homecare dermatology energy based devices market.

Adding further to the information about the market competition, the analyst says, “A majority of companies are prioritizing product innovations in LED, IR, and lasers segments. Moreover, a large number of market players are taking efforts for extended product reach through retail partnerships, in addition to NPD for a wider application base. Companies are also observed to be focusing on collaborations and acquisitions to reshape their product distribution strategy for better profitability”.

FDA Approvals Are Relatively Easy

Relatively easy and faster FDA approvals for homecare dermatology energy based devices are driving improved appearance of these devices in tandem with the latest handheld gadgets, which prominently curtail the need for frequent visits to professional cosmetic treatment centers.

A recent example includes FDA clearance for Titan – the anti-aging device launched by Skinovations Inc. later in 2017.

On a similar line, North American and European markets for homecare dermatology energy based devices are witnessing remarkable adoption in recent years. FMI identifies a slew of business expansion opportunities in the aforementioned regions for manufacturers of homecare dermatology energy based devices.

Moreover, growing R&D efforts as manufacturers in the US zoom in on the production quality, is likely to shape the performance of North America’s market for homecare dermatology energy based devices.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-7699

Combination of Technologies for Better Treatment Output

Making the most of the best attributes of LED and lasers technologies, a new trend among manufacturers now involves the combination of both the technologies for manufacturing homecare dermatology energy based devices. While these devices are claimed to be effectively reducing fine lines and improving skin tone with LED, lasers enable them to be highly target specific. A recent example is of YA-MAN’s RF Beaute Photo PLUS.

About FMI:

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Endoscopy Fluid Management Systems Market is predicted to expand at a 7.4% CAGR to reach a net worth of US$ 683 Mn by 2028

[187 Pages Report] According to the FMI study, as the Tier 1 players continue to contribute over 70% share of the market revenue, the global endoscopy fluid management systems landscape remains a highly consolidated space.

Providing a brief overview of the FDA regulations for Class II medical devices such as endoscopes, a new study presented by Future Market Insights offers an exhaustive assessment of the global endoscopy fluid management systems landscape for a 10-year projection period, 2018-2028.

The report covers extensive profiling of the top four performers including a few of the biggest industry names such as Stryker Corporation and Olympus Corporation. However, research indicates that even local players have strong penetration in regional markets.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4358

Top 3 Insights from Key Players Analysis

While a majority of companies are focusing on new product launches, strategic mergers and acquisitions are likely to emerge the most profitable developmental decisions in the near future. Most of these strategic moves will be primarily directed to address the high price point pressure associated with endoscopy fluid management systems that often affects revenue growth in developing economies.

Major hospital networks in developed regional markets are witnessing M&A between hospitals, which is likely to shape costing of medical devices such as endoscopy fluid management systems – eventually slashing down the profitability margins of manufacturers. “Constantly increasing chronic disease instances, coupled with immense technological advances in the field of endoscopy, is prominently driving the US$ 342 Million market for endoscopy fluid management systems (or irrigation pumps) in recent years,” says a senior research analyst at the company.

Prominent Players:

Karl Storz GmbH & Co KG
Olympus Corporation
Richard Wolf GmbH
Smith & Nephew
Stryker Corporation
DePuy Synthes (Johnson & Johnson Services Inc.)
Cantel Medical Corporation
Medtronics Plc.
B. Braun Medical Inc. and Hologic Inc

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-4358

Top 5 Insights from Segmental Analysis

With maximum use in laparoscopic procedures, endoscopy fluid management systems continue to register maximum revenue generation through sales of laparoscopy suction irrigation pumps, followed by laparoscopy fluid management systems.

Based on the modality of endoscopy fluid management systems, the Benchtop holds a substantial market value share.

Hospitals register the highest consumption of endoscopy fluid management systems.

Owing to a massive number of cancer survivors in the US, North America’s market for endoscopy fluid management systems is currently accounting for the largest revenue share in the global landscape, followed by Asia Pacific and Europe.

MEA and Latin America are likely to represent a significant incremental opportunity, according to FMI study.

Healthy Year over Year Revenue Growth Projected for Asia Pacific

APAC has become the hotspot for leading medical device companies, which is further intensified by dramatically growing medical tourism sector. Across APAC, Japan is likely to account for substantial revenue generation, enabling the regional market secure second spot in the global endoscopy fluid management systems landscape. FMI projects over 7% year on year revenue growth in 2020 and beyond, for this regional market.

Government Regulations Favor Market Growth in Latin America

Latin American market for endoscopy fluid management systems is thriving at a promising pace owing to favorable government initiatives regarding endoscopic procedures and medical device marketing. Noteworthy demand for laparoscopy suction irrigation pumps within the region is identified to be responsible for the rapid revenue growth of endoscopy fluid management systems marketplace across Latin America.

Egypt’s End Users Drive Market Growth in MEA

The market for endoscopy fluid management systems in MEA is prominently driven by the improving regulatory landscape related to the marketing of medical devices, pushed further by impressive sales of laparoscopy suction irrigation pump based endoscopy fluid management systems. FMI spots higher market attractiveness in Egypt owing to the presence of a large number of end users. However, poor operational environment still remains a major growth barrier for the region.

For in-depth competitive analysis Buy Now – https://www.futuremarketinsights.com/checkout/4358

Segmentation

The report offers a comprehensive taxonomy of the endoscopy fluid management systems market based on product type, end user, modality and region. Endoscopy fluid management systems are used for various types of endoscopic surgeries such as hysteroscopy and laparoscopy.. End-user segments in the endoscopy fluid management systems market include hospitals, ambulatory surgical centers and other end users, such as specialty clinics & diagnostic centers.

From a regional perspective, the endoscopy fluid management systems market has been analyzed across North America, Latin America, Europe, Asia Pacific and Middle East & Africa.

About FMI:

Cell Line Development Market is forecast to reach a valuation of US$ 4.7 Billion in 2022 | FMI

[329 Pages Report] According to a latest research by Future Market Insights (FMI), the global cell line development market size is anticipated to account for over US$ 7,200 Mn, in terms of value, by 2028 end. The report on cell line development market further projects significant growth potential with CAGR at 7.2% through 2028.

According to International Agency for Research on Cancer, the number of new cancer cases per year is expected to rise to 23.6 million by 2030 globally. In recent times, cell line development and its applications are considered as potential tools in oncology research. Cell lines are projected to be used for development of new treatment pathway for various disease including cancer and neurological diseases.

Rapid increase in prevalence of cancer and neurology disorders and lack of efficient treatment solution for these diseases has created the need of more advanced and efficient treatment pathway. Companies and government organizations are investing on research and development activities and are also focusing more on cell line development in search of new cellular pathway to develop novel drugs. The increased spending on biosimilar R&D from exiting biopharmaceutical companies would provide boost to cell line development market.

In recent time the contract research organizations are focusing on cell line development and cell line research activities. According to National Institutes of Health (NIH) the estimated total federal spending on all type of stem cell line research for 2017 is US$ 1.58 Bn. In developing countries like India, government is supporting cell line development through national funding agencies like Department of Biotechnology (DBT), Indian Council of Medical Research (ICMR), and Department of Science and Technology (DST).

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-7566

Regenerative medicines are the next generation treatment solution and Cell Line Development or Cell Culture is a vital part for regenerative medicine. Increasing demand of regenerative medicines in cancer treatment would positively impacting the growth of Cell Line Development market over the forecast period.

The biopharmaceutical companies operating in development of novel drug line are expected to hold promising revenue opportunity in cell line development market.

Future Market Insights (FMI) has segmented the cell line development market based on product type, cell line source type, end user, type of cell line and region.

Product type segment in cell line development market is segmented into media and reagents, equipment and accessories. Reagents and Media are required from incubation to preservation of cell lines. These products are expensive and have repetitive use in cell culture or bio-production. Reagent and media segment in cell line development market is expected witness noteworthy growth in terms of revenue owing to rapid increase in demand in cell culture and cell based assays.

Cell line development market by cell line source is categorized into mammalian cells and non-mammalian cells. Mammalian cell line development is anticipate to witness significant growth in overall cell line development market. This growth of mammalian cells segment in cell line development market is driven by increased production of biologics drugs which require mammalian cells. Increasing antibody production is the major driving factor behind the growth of mammalian cell lines segment in cell line development market.

Mammalian cell lines are used to create therapeutic proteins through genetic building and antibodies through viral infection. For example, Gaucher’s disease, which is a genetic disorder characterized by lack of β-glucocerebrosidase enzyme and can be treated by Cerezyme which is a recombinant enzyme produces in mammalian cell lines. Mammalian cell lines are also useful in production of antibodies and other therapeutic agents such as specific binding proteins that can neutralize disease causing agents in the body. For example Under cell line type segment in cell line development market, recombinant cell line development are the most demanding type of cell line due to large application in biologics production, protein interaction, gene activation, toxicity testing and drug screening.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-7566

Growing application recombinant cell line development in drug toxicity testing is expected to boost the growth of overall cell line development during the forecast period

North America and Europe cell line development market will dominate in owing to increasing government funding in cell line development research and rising spending on biosimilar developments. Asia Pacific cell line development market is expected to grow at a high growth rate due to increased number of research organization engaged in novel biologics and biosimilar fastest revenue growth in overall cell line development market.

The Asia Pacific region in Cell line development market is anticipate to witness increasing demand of biopharmaceuticals and regenerative medicines are expected to boost the growth of the cell line development market.

FMI’s report tracks some of the key companies operating in the cell line development market, such as Selexis SA, GE Healthcare, Corning Incorporated, Thermo Fischer Scientific, Inc., American Type Culture Collection (ATCC), Lonza (Sartorius Stedim Biotech S.A.), Danaher Corporation, Merck KGaA, WuXi Biologics.

Key Market Segments Covered in Cell line development Market Research By Product Type:

Reagent and Media
Equipment
Accessories and consumables

By Source Type:

Mammalian cell line
Non-mammalian cell line

By End User:

Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
Biotechnology Companies

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-7566

By Cell Lines:

Recombinant cell lines
Hybridomas
Continuous cell lines
Primary cell lines

About FMI:

Pharma Grade Synthetic Camphor Market is projected to register the growth of 4.2% CAGR from 2022 to 2028

[253 Pages Report] According to the latest research by the company, the global pharma-grade synthetic camphor market size is anticipated to be valued at US$ 532.0 Mn, by 2028 end.

The report on pharma-grade synthetic camphor market further projects significant growth potential with average year-on-year growth rate pegged at 4.1% through 2028.

Growing demand for topical pain management products is expected to propel the growth of pharma-grade synthetic camphor market. Pharma-grade synthetic camphor is used in many topical analgesic products such as oils, ointments, chest rubs, and gel.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-7564

These pharma-grade synthetic camphor pain management products are experiencing significant growth due to lesser side effect compare to oral analgesic and expanded retail channel access. Increasing self-medication rate and availability of cost-effective camphor contained OTC analgesic favors the growth of pharma-grade synthetic camphor market growth.

pharma grade synthetic camphor market

Growing incidence of infectious diseases such as cold, flu augmented the use of cold sore remedies, nasal decongestants, topical expectorants etc. which in turn would drive the growth of pharma-grade synthetic camphor market. Increasing use of private labeled topical products containing camphor push the demand for pharma-grade synthetic camphor.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-7564

Private label analgesic is gaining popularity in the U.S. market as they do not require FDA approval and strong promotion activities by retailers. Walgreens Ultra Strength Muscle Rub (4% camphor), Salonpas pain relieving patch (1.2% camphor) are the examples of private label analgesic which contain camphor. Surge in commodity export, economic growth and production capacity are expected to boost the growth of pharma-grade synthetic camphor market.

However, regulatory restrictions on the use of camphor in the medicine of pharmaceutical products would considerably impact the growth of pharma-grade synthetic camphor market. Moreover, increasing raw material prices are expected to hamper the growth of pharma-grade synthetic camphor market. Thus, growing prices of raw materials i.e. alpha pinene or turpentine oil is a major challenge for the manufacturers of pharma-grade synthetic camphor.

Company has segmented the global pharma-grade synthetic camphor market into formulation, application, distribution, and regions. Based on the formulation, pharma-grade synthetic camphor market is segmented into topical and inhalation. The topical segment is expected to represent a highest revenue share in pharma-grade synthetic camphor market as high number of marketed products and vast applications.

Applications of pharma-grade synthetic camphor included in the report are respiratory disorders applications, muscular rheumatism, counterirritant & antipruritic and others (topical analgesic, cold sores, minor burns, antifungal, hemorrhoids, topical antitussive & expectorant, astringent, rubefacient, etc.). Others segment expected to contributes highest market value in global pharma-grade synthetic camphor market. Based on the distribution channel, pharma-grade synthetic camphor market is segmented into conventional B2B and online B2B channel. In terms of revenue, conventional B2B segment would hold significant revenue share in pharma-grade synthetic camphor market over the forecast period.

On the basis of region, the global pharma-grade synthetic camphor market has been segmented into North America, Latin America, Western Europe, Eastern Europe, the Asia Pacific excluding China & Japan, China, Japan, and the Middle East & Africa. North America is expected to contribute highest revenue share in global pharma-grade synthetic camphor market.

The demand of pharma-grade synthetic camphor has increased in North America, as increasing production of camphor contained private label and OTC products. China is expected to witness the highest growth rate in pharma-grade synthetic camphor market due to presence of the larger number of pharma-grade synthetic camphor manufactures. Pharma-grade synthetic camphor manufactures are mainly concentrated in China and India and they export their chemicals to the U.S. and Europe. Moreover, due to its growing contribution to the global industry, Asia Pacific is emerging as a focused destination for global manufacturers of camphor and related chemicals.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/7564

Report tracks some of the key companies operating in the global pharma-grade synthetic camphor market. Representative players included in the global pharma-grade synthetic camphor market report are Merck KGaA, Oriental Aromatics Limited, Saptagir Camphor Limited, Mangalam Organics Limited, Nippon Fine Chemical Co., Ltd., Rochem International, Inc., Spectrum Chemical Mfg. Corp., Aldon Corporation, Prinova Group LLC. and Fengchen Group Co., Ltd. Manufactures are focusing on improvement of the supply chain which expected to provide huge opportunities to them over the forecast period.

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Next Generation Optical Biometry Devices Market is projected to rise at a CAGR of around 5.4% through 2028 | FMI

[248 Pages Report] Increasing incidence of eye diseases such as cataract and refractive errors coupled with rising number of eye care clinics and hospitals globally are factors increasing the adoption of next generation optical biometry devices.

With the advancement in the technology, next generation optical biometry devices have been developed aiding measurement of eyes before cataract and refractive surgeries. Earlier measurement by ultrasound technique was gold standard. However, unlike next generation optical biometry devices, ultrasound devices require direct contact of the probe, which lead to many eye infections.

The next generation optical biometry devices are automated and measure many parameters such as the axial length, anterior chamber depth, thickness of the lens, retinal thickness, pupil size and many more.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7556

The next generation optical biometry devices are an accurate alternative for the precise measurements and provide efficient results. Also the next generation optical biometry devices avoid the operator variations measurements.

Research indicates next generation optical biometry devices market is anticipated to account for revenues over US$ 450 Mn, by 2028 end. The report on next generation optical biometry devices projects market revenues to expand at a CAGR of 5.1% through 2028.

According to Prevent Blindness organization, ~25 Mn Americans having cataract require medical care every year in the U.S., hence boosting demand for next generation optical biometry devices.

Similar rising demand for next generation optical biometry devices is noted in UK with rising number of cataract surgeries. Increased demand for next generation optical biometry devices is noted in developing markets concurrent with access to eye care facilities.

Next generation optical biometry devices are all-in one devices used for evaluation of lens and refraction, of retina.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-7556

Next Generation Optical Biometry Devices Market: Overview & Analysis

Rapid increase in number of probe infections due to usage of ultrasound devices, lead to post-operative errors fuelling demand for next generation optical biometry devices instead of ultrasound biometry devices.

Manufacturers of next generation optical biometry devices are introducing automated devices which are more efficient in measuring segments of eyes. Players in next generation optical biometry devices market are working on strengthening the software, which could provide detailed information about eye segments.

New next generation optical biometry devices introduced are taking into account irregularities and astigmatisms of the anterior and the posterior surfaces of the eye.

The next generation optical biometry devices uses a partially coherent wave that has approximately 9x the resolution of a 10 MHz sound wave, for precise measurement of axial length.

Hospitals end users segment account for 41.8% revenue share in the global Next Generation Optical biometry Devices market. Medical services and vision benefits offered under Medicare includes cataract surgeries; which will increase the demand of next generation optical biometry devices.

Increasing geriatric population and rising income in Japan is expected to surge the demand for more advanced Next Generation Optical biometry Devices. Japan Next Generation Optical biometry Devices market is estimated to create absolute $ opportunity worth approximately US$ 1.21 Mn between 2017 and 2028.

The company has segmented the global Next Generation Optical Biometry Devices Market into product type and end users. In terms of revenue, the swept source segment in product type in next generation optical biometry devices market report will account for significant revenue share over the forecast period.

In contrary, the Partial coherence interferometry (PCI) based next generation optical biometry devices segment in all the markets will exhibit limited investment opportunities through 2028 in next generation optical biometry devices market.

Next Generation Optical Biometry Devices Market: Key Players

The next generation optical biometry devices market report tracks some of the key companies, such as Carl Zeiss AG, Nidek Co Ltd, Haag-Streit AG(Metall Zug AG), Ziemer Ophthalmic Systems, Optovue, Incorporated, Topcon Corporation, TOMEY GmbH, Movu Inc. (unit of Santec Corporation) , Newway Technology and OCULUS Optikgeräte GmbH. The largest player in the next generation optical biometry devices market is Carl Zeiss AG with its IOL masters and Haag-Streit AG’s Lenstar.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/7556

Key Segments of Next Generation Optical Biometry Devices Industry SurveyNext Generation Optical Biometry Devices Market by Product Type

Swept-Source Optical Coherence Tomography (OCT) Based Biometers
Partial Coherence Interferometry (PCI) Based Biometers
Optical Low Coherence Reflectometry (OLCR) Based Biometers

Next Generation Optical Biometry Devices Market by End User

Hospitals
Ophthalmology Clinics and Specialized Eye Care Centers
Ambulatory Surgical Centers

About FMI:

Preterm Birth Diagnostic Test Kits Market is projected to reach U.S. $ 203.2 Mn by the end of 2028

[257 Pages Report] According to Future Market Insights (FMI), the global Preterm Birth Diagnostic Test Kits Market was worth US$ 121.3 Mn in 2021 and is expected to grow 1.6X during the forecast period. During the forecast period of 2022-2028, the market is expected to grow at a CAGR of 7.6%, with sales of US $ 203.2 Mn in 2028.

A new study by the company titled ‘Preterm Birth Diagnostic Test Kits Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028’, has listed out the key points being considered by preterm birth diagnostic test kits companies to emerge and stay sustainably profitable in the long run in the preterm birth diagnostic test kits market.

The global preterm birth diagnostic test kits market is expected to expand at a CAGR of 7.4% over the forecast period to reach a value of over US$ 200 Mn by 2028, and the North America preterm birth diagnostic test kits market is expected to remain as a main sink market for revenues. Europe is expected to remain as the main source market for preterm birth diagnostic test kits, as most of the preterm birth diagnostic test kits facilities are located in this region. However, with the increasing demand and cost-effective diagnostic options in countries such as China and India, and various countries of Asia Pacific and Middle-East, is fueling the growth of preterm birth diagnostic test kits market.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7551

Key Findings Presented in the Report on the Preterm Birth Diagnostic Test Kits Market

The report finds that approximately 115.4 million births occurred in 2017, out of which 11.1% births were preterm, which is approximately 12.8 million births. As per WHO, preterm birth complications are the leading cause of deaths amongst children under the age of 5, directly responsible for approximately 1 million death in 2015. Out of these, 3/4th of these deaths can be prevented with cost-effective interventions. The adoption rates for preterm birth diagnostic tests kits ranged from 2% to 15% distributed over various geographies. Majority of the existent patient pool are unaware about the cost-saving benefits of preterm birth diagnostic test kits, thus, a major portion on the preterm birth test kits market has remained untapped which remains open for manufactures of preterm diagnostic test kits to exploit the preterm birth diagnostic test kits market over the forecast period.

Analysis of the Preterm Birth Diagnostic Test Kits Market

For preterm birth diagnostic test kits, blood sample is the most common sample take for diagnosing preterm labor and premature rupture of membrane. Blood sample-based preterm birth diagnostic tests in preterm cases are the most common and widely accepted in the preterm birth diagnostic test kits end users. However, vaginal discharge sample type preterm birth diagnostic tests are gaining popularity for preterm birth diagnostic test kits.

Hospitals, outpatient clinics & diagnostic laboratories using preterm birth diagnostic tests are the primary point of contact for patients experiencing preterm birth symptoms. Hospitals are estimated to account for majority of the revenue share under the end users segment for preterm birth diagnostic test kits market in 2017, owing to being the primary healthcare facility for preterm cases. The prevalent cases of preterm birth, growing demand for cost-effective diagnostic options and preterm birth test kits, and success in clinical studies for developing a rapid preterm birth diagnostic test kits is expected to fuel the growth of the global preterm birth diagnostic test kits market over the forecast period.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-7551

Activities across the preterm birth diagnostic test kits manufacturers are restricted to efficiency and specificity testing. The top activity associated with preterm birth diagnostic test kits manufacturers is joint collaboration with various organizations in order to spread awareness, further development, and test the sensitivity, specificity and efficiency of preterm birth diagnostic test kits.

Factors Impacting Growth of the Preterm Birth Diagnostic Test Kits Market

Rising focus on cost-effective diagnosis using preterm birth diagnostic test kits is expected to boost the growth of the preterm birth diagnostic test kits market. Preterm birth diagnostic test kits manufacturing companies focusing on spreading awareness about preterm birth diagnostic test kits and marketing preterm birth diagnostic test kits through campaigns and joint research studies is expected fuel the growth of the preterm birth diagnostic test kits market during the forecast period. However, Preterm birth diagnostic kits experience stiff competition from alternative product lines. Trans-vaginal scans, advanced ultrasound are some of the examinations adopted by healthcare providers over preterm birth diagnostic kits and would pose challenges to the growth of the preterm birth diagnostic test kits market.

Preterm Birth Diagnostic Test Kits Market: Companies

Some of the key preterm birth diagnostic test kits companies analyzed in this report titled Preterm birth diagnostic test kits market include Creative Diagnostics, Qiagen, Medixbiochemcia, Hologic Inc, Sera Prognostics, IQ Products, Biosynex, Nanjing Liming Biological Preparations Co Ltd, Clinical Innovations LLC, BIOSERV Diagnostics GmbH, Wuxi BioHermes Biomedical Technology Co. Ltd, and Anhui Deep Blue Medical Technology.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/7551

Preterm Birth Diagnostic Test Kits Market, By Category

Product:

ffN Test
PAMG-1 Test
IGFBP-1 Test

Sample:

Blood
Urine
Vaginal Discharge

End User:

Hospitals
Diagnostic Laboratories
Outpatient Clinics
Research Centers

About FMI: